Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.

Kleiner DE, Brunt EM, Wilson LA, Behling C, Guy C, Contos M, Cummings O, Yeh M, Gill R, Chalasani N, Neuschwander-Tetri BA, Diehl AM, Dasarathy S, Terrault N, Kowdley K, Loomba R, Belt P, Tonascia J, Lavine JE, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network.

JAMA Netw Open. 2019 Oct 2;2(10):e1912565. doi: 10.1001/jamanetworkopen.2019.12565.

2.

Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials.

Pai RK, Kleiner DE, Hart J, Adeyi OA, Clouston AD, Behling CA, Jain D, Kakar S, Brahmania M, Burgart L, Batts KP, Valasek MA, Torbenson MS, Guindi M, Wang HL, Ajmera V, Adams LA, Parker CE, Feagan BG, Loomba R, Jairath V.

Aliment Pharmacol Ther. 2019 Nov;50(10):1100-1111. doi: 10.1111/apt.15503. Epub 2019 Oct 3.

PMID:
31583739
3.

Clinical utility of an increase in magnetic resonance elastography in predicting fibrosis progression in NAFLD.

Ajmera VH, Liu A, Singh S, Yachoa G, Ramey M, Bhargava M, Zamani A, Lopez S, Mangla N, Bettencourt R, Rizo E, Valasek M, Behling C, Richards L, Sirlin C, Loomba R.

Hepatology. 2019 Sep 25. doi: 10.1002/hep.30974. [Epub ahead of print]

PMID:
31556124
4.

Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.

Schwimmer JB, Johnson JS, Angeles JE, Behling C, Belt PH, Borecki I, Bross C, Durelle J, Goyal NP, Hamilton G, Holtz ML, Lavine JE, Mitreva M, Newton KP, Pan A, Simpson PM, Sirlin CB, Sodergren E, Tyagi R, Yates KP, Weinstock GM, Salzman NH.

Gastroenterology. 2019 Oct;157(4):1109-1122. doi: 10.1053/j.gastro.2019.06.028. Epub 2019 Jun 27.

PMID:
31255652
5.

The effect of n-3 long-chain polyunsaturated fatty acids and lipoic acid on the heart in the ovariectomized rat model of menopause.

Marinho PM, Salomon TB, Andrade AS, Behling CS, Putti JS, Benfato MS, Hackenhaar FS.

Free Radic Res. 2019 Jun;53(6):669-679. doi: 10.1080/10715762.2019.1620938. Epub 2019 Jun 4.

PMID:
31106614
6.

Haptoglobin 2 Allele is Associated With Histologic Response to Vitamin E in Subjects With Nonalcoholic Steatohepatitis.

Banini BA, Cazanave SC, Yates KP, Asgharpour A, Vincent R, Mirshahi F, Le P, Contos MJ, Tonascia J, Chalasani NP, Kowdley KV, McCullough AJ, Behling CA, Schwimmer JB, Lavine JE, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN).

J Clin Gastroenterol. 2019 Nov/Dec;53(10):750-758. doi: 10.1097/MCG.0000000000001142.

PMID:
30586008
7.

Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease.

Bashir MR, Wolfson T, Gamst AC, Fowler KJ, Ohliger M, Shah SN, Alazraki A, Trout AT, Behling C, Allende DS, Loomba R, Sanyal A, Schwimmer J, Lavine JE, Shen W, Tonascia J, Van Natta ML, Mamidipalli A, Hooker J, Kowdley KV, Middleton MS, Sirlin CB; NASH Clinical Research Network (NASH CRN).

J Magn Reson Imaging. 2019 May;49(5):1456-1466. doi: 10.1002/jmri.26312. Epub 2018 Oct 14.

PMID:
30318834
8.

Hepatic Nuclear Receptor Expression Associates with Features of Histology in Pediatric Nonalcoholic Fatty Liver Disease.

Elbel EE, Lavine JE, Downes M, Van Natta M, Yu R, Schwimmer JB, Behling C, Brunt EM, Tonascia J, Evans R.

Hepatol Commun. 2018 Sep 27;2(10):1213-1226. doi: 10.1002/hep4.1232. eCollection 2018 Oct.

9.

Exome sequencing of an adolescent with nonalcoholic fatty liver disease identifies a clinically actionable case of Wilson disease.

Wattacheril J, Shea PR, Mohammad S, Behling C, Aggarwal V, Wilson LA, Yates KP, Ito J, Fishbein M, Stong N, Lavine JE, Goldstein DB.

Cold Spring Harb Mol Case Stud. 2018 Oct 1;4(5). pii: a003087. doi: 10.1101/mcs.a003087. Print 2018 Oct.

10.

Mild Therapeutic Hypothermia Increases Glutathione Levels in Postcardiac Arrest Patients.

Hackenhaar FS, Medeiros TM, Heemann FM, Behling CS, Mahl CD, Verona C, Silva ACA, Oliveira VM, Riveiro DFM, Vieira SRR, Benfato MS.

Ther Hypothermia Temp Manag. 2019 Mar;9(1):63-69. doi: 10.1089/ther.2018.0012. Epub 2018 Jul 17.

PMID:
30016204
11.

Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease.

Harlow KE, Africa JA, Wells A, Belt PH, Behling CA, Jain AK, Molleston JP, Newton KP, Rosenthal P, Vos MB, Xanthakos SA, Lavine JE, Schwimmer JB; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN).

J Pediatr. 2018 Jul;198:76-83.e2. doi: 10.1016/j.jpeds.2018.02.038. Epub 2018 Apr 13.

12.

Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Ajmera V, Park CC, Caussy C, Singh S, Hernandez C, Bettencourt R, Hooker J, Sy E, Behling C, Xu R, Middleton MS, Valasek MA, Faulkner C, Rizo E, Richards L, Sirlin CB, Loomba R.

Gastroenterology. 2018 Aug;155(2):307-310.e2. doi: 10.1053/j.gastro.2018.04.014. Epub 2018 Apr 13.

13.

Novel Fully Organic Water Oxidation Electrocatalysts: A Quest for Simplicity.

Wu Y, Klein V, Killian MS, Behling C, Chea S, Tsogoeva SB, Bachmann J.

ACS Omega. 2018 Mar 31;3(3):2602-2608. doi: 10.1021/acsomega.7b01982. Epub 2018 Mar 5.

14.

Therapeutic Hypothermia Reduces Oxidative Damage and Alters Antioxidant Defenses after Cardiac Arrest.

Hackenhaar FS, Medeiros TM, Heemann FM, Behling CS, Putti JS, Mahl CD, Verona C, da Silva ACA, Guerra MC, Gonçalves CAS, Oliveira VM, Riveiro DFM, Vieira SRR, Benfato MS.

Oxid Med Cell Longev. 2017;2017:8704352. doi: 10.1155/2017/8704352. Epub 2017 May 1.

15.

Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease.

Schwimmer JB, Behling C, Angeles JE, Paiz M, Durelle J, Africa J, Newton KP, Brunt EM, Lavine JE, Abrams SH, Masand P, Krishnamurthy R, Wong K, Ehman RL, Yin M, Glaser KJ, Dzyubak B, Wolfson T, Gamst AC, Hooker J, Haufe W, Schlein A, Hamilton G, Middleton MS, Sirlin CB.

Hepatology. 2017 Nov;66(5):1474-1485. doi: 10.1002/hep.29241. Epub 2017 Oct 9.

16.

Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children.

Newton KP, Feldman HS, Chambers CD, Wilson L, Behling C, Clark JM, Molleston JP, Chalasani N, Sanyal AJ, Fishbein MH, Lavine JE, Schwimmer JB; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN).

J Pediatr. 2017 Aug;187:141-146.e1. doi: 10.1016/j.jpeds.2017.03.007. Epub 2017 Mar 30.

17.

In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis.

Africa JA, Behling CA, Brunt EM, Zhang N, Luo Y, Wells A, Hou J, Belt PH, Kohil R, Lavine JE, Molleston JP, Newton KP, Whitington PF, Schwimmer JB; Nonalcoholic Steatohepatitis Clinical Research Network.

Clin Gastroenterol Hepatol. 2018 Mar;16(3):438-446.e1. doi: 10.1016/j.cgh.2017.02.030. Epub 2017 Mar 7.

18.

Liver histology and diffusion-weighted MRI in children with nonalcoholic fatty liver disease: A MAGNET study.

Manning P, Murphy P, Wang K, Hooker J, Wolfson T, Middleton MS, Newton KP, Behling C, Awai HI, Durelle J, Paiz MN, Angeles JE, De La Pena D, McCutchan JA, Schwimmer JB, Sirlin CB.

J Magn Reson Imaging. 2017 Oct;46(4):1149-1158. doi: 10.1002/jmri.25663. Epub 2017 Feb 22.

19.

RehaMovePro: A Versatile Mobile Stimulation System for Transcutaneous FES Applications.

Valtin M, Kociemba K, Behling C, Kuberski B, Becker S, Schauer T.

Eur J Transl Myol. 2016 Jun 13;26(3):6076. eCollection 2016 Jun 13.

20.

Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.

Newton KP, Hou J, Crimmins NA, Lavine JE, Barlow SE, Xanthakos SA, Africa J, Behling C, Donithan M, Clark JM, Schwimmer JB; Nonalcoholic Steatohepatitis Clinical Research Network.

JAMA Pediatr. 2016 Oct 3;170(10):e161971. doi: 10.1001/jamapediatrics.2016.1971. Epub 2016 Oct 3.

21.

Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.

Loomba R, Cui J, Wolfson T, Haufe W, Hooker J, Szeverenyi N, Ang B, Bhatt A, Wang K, Aryafar H, Behling C, Valasek MA, Lin GY, Gamst A, Brenner DA, Yin M, Glaser KJ, Ehman RL, Sirlin CB.

Am J Gastroenterol. 2016 Jul;111(7):986-94. doi: 10.1038/ajg.2016.65. Epub 2016 Mar 22.

22.

Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models.

Schnabl B, Farshchi-Heydari S, Loomba R, Mattrey RF, Hoh CK, Sirlin CB, Brenner DA, Behling CA, Vera DR.

Nucl Med Biol. 2016 Feb;43(2):179-87. doi: 10.1016/j.nucmedbio.2015.11.009. Epub 2015 Dec 2.

PMID:
26872443
23.

Treatment of oxidative stress in brain of ovariectomized rats with omega-3 and lipoic acid.

Behling CS, Andrade AS, Putti JS, Mahl CD, Hackenhaar FS, da Silva AC, e Silva MN, Salomon TB, Dos Santos CE, Dias JF, Benfato MS.

Mol Nutr Food Res. 2015 Dec;59(12):2547-55. doi: 10.1002/mnfr.201500338. Epub 2015 Sep 22.

PMID:
26394051
24.

Induction of ROS generation by fluconazole in Candida glabrata: activation of antioxidant enzymes and oxidative DNA damage.

Mahl CD, Behling CS, Hackenhaar FS, de Carvalho e Silva MN, Putti J, Salomon TB, Alves SH, Fuentefria A, Benfato MS.

Diagn Microbiol Infect Dis. 2015 Jul;82(3):203-8. doi: 10.1016/j.diagmicrobio.2015.03.019. Epub 2015 Apr 9.

PMID:
25935629
25.

Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.

Arulanandan A, Ang B, Bettencourt R, Hooker J, Behling C, Lin GY, Valasek MA, Ix JH, Schnabl B, Sirlin CB, Loomba R.

Clin Gastroenterol Hepatol. 2015 Aug;13(8):1513-20.e1. doi: 10.1016/j.cgh.2015.01.027. Epub 2015 Feb 3.

PMID:
25661453
26.

Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.

Schwimmer JB, Middleton MS, Behling C, Newton KP, Awai HI, Paiz MN, Lam J, Hooker JC, Hamilton G, Fontanesi J, Sirlin CB.

Hepatology. 2015 Jun;61(6):1887-95. doi: 10.1002/hep.27666. Epub 2015 Feb 5.

27.

Longitudinal assessment of high blood pressure in children with nonalcoholic fatty liver disease.

Schwimmer JB, Zepeda A, Newton KP, Xanthakos SA, Behling C, Hallinan EK, Donithan M, Tonascia J; Nonalcoholic Steatohepatitis Clinical Research Network.

PLoS One. 2014 Nov 24;9(11):e112569. doi: 10.1371/journal.pone.0112569. eCollection 2014.

28.

Reproducibility of histological assessments of disease activity in UC.

Mosli MH, Feagan BG, Zou G, Sandborn WJ, D'Haens G, Khanna R, Behling C, Kaplan K, Driman DK, Shackelton LM, Baker KA, MacDonald JK, Vandervoort MK, Samaan MA, Geboes K, Valasek MA, Pai R, Langner C, Riddell R, Harpaz N, Sewitch M, Peterson M, Stitt LW, Levesque BG.

Gut. 2015 Nov;64(11):1765-73. doi: 10.1136/gutjnl-2014-307536. Epub 2014 Oct 30.

PMID:
25360036
29.

Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults.

Murphy P, Hooker J, Ang B, Wolfson T, Gamst A, Bydder M, Middleton M, Peterson M, Behling C, Loomba R, Sirlin C.

J Magn Reson Imaging. 2015 Jun;41(6):1629-38. doi: 10.1002/jmri.24755. Epub 2014 Sep 25.

30.

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.

Loomba R, Wolfson T, Ang B, Hooker J, Behling C, Peterson M, Valasek M, Lin G, Brenner D, Gamst A, Ehman R, Sirlin C.

Hepatology. 2014 Dec;60(6):1920-8. doi: 10.1002/hep.27362. Epub 2014 Oct 29. Erratum in: Hepatology. 2015 Nov;62(5):1646.

31.

Beyond incentives: the impact of health care reform on employer population health management strategies.

Sherman BW, Behling C.

Popul Health Manag. 2014 Apr;17(2):67-70. doi: 10.1089/pop.2013.0077. Epub 2014 Mar 10. No abstract available.

PMID:
24611916
32.

Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices.

Mosli MH, Feagan BG, Sandborn WJ, Dʼhaens G, Behling C, Kaplan K, Driman DK, Shackelton LM, Baker KA, Macdonald JK, Vandervoort MK, Geboes K, Levesque BG.

Inflamm Bowel Dis. 2014 Mar;20(3):564-75. doi: 10.1097/01.MIB.0000437986.00190.71. Review.

PMID:
24412993
33.

Alpha-lipoic acid restores tear production in an animal model of dry eye.

Andrade AS, Salomon TB, Behling CS, Mahl CD, Hackenhaar FS, Putti J, Benfato MS.

Exp Eye Res. 2014 Mar;120:1-9. doi: 10.1016/j.exer.2013.12.014. Epub 2014 Jan 4.

PMID:
24394592
34.

Evidence and recommendations for imaging liver fat in children, based on systematic review.

Awai HI, Newton KP, Sirlin CB, Behling C, Schwimmer JB.

Clin Gastroenterol Hepatol. 2014 May;12(5):765-73. doi: 10.1016/j.cgh.2013.09.050. Epub 2013 Sep 30. Review.

35.

Oxidative stress in the kidney of reproductive female rats during aging.

da Silva AC, Salomon TB, Behling CS, Putti J, Hackenhaar FS, Alabarse PV, Schüller AK, Benfato MS.

Biogerontology. 2013 Aug;14(4):411-22. doi: 10.1007/s10522-013-9440-9. Epub 2013 Jul 3.

PMID:
23820883
36.

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.

Noureddin M, Yates KP, Vaughn IA, Neuschwander-Tetri BA, Sanyal AJ, McCullough A, Merriman R, Hameed B, Doo E, Kleiner DE, Behling C, Loomba R; NASH CRN.

Hepatology. 2013 Nov;58(5):1644-54. doi: 10.1002/hep.26465. Epub 2013 Oct 2.

37.

An employer's dilemma: integrating existing population health management programs with evolving health care delivery models.

Sherman BW, Behling C.

Popul Health Manag. 2011 Aug;14(4):157-9. doi: 10.1089/pop.2011.0010. No abstract available.

PMID:
21834703
38.

Misuse of scoring systems.

Brunt EM, Kleiner DE, Behling C, Contos MJ, Cummings OW, Ferrell LD, Torbenson MS, Yeh M.

Hepatology. 2011 Jul;54(1):369-70; author reply 370-1. doi: 10.1002/hep.24347. No abstract available.

PMID:
21488072
39.

The ghosts of disease management past.

Behling C.

Popul Health Manag. 2010 Apr;13(2):57-8. doi: 10.1089/pop.2010.1321. No abstract available.

PMID:
20415616
40.

Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.

Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TT, Rosenthal P, Sanyal AJ, Schwimmer JB, Lavine JE.

Am J Gastroenterol. 2010 Sep;105(9):2093-102. doi: 10.1038/ajg.2010.152. Epub 2010 Apr 6.

41.

Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease.

Kistler KD, Molleston J, Unalp A, Abrams SH, Behling C, Schwimmer JB; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN).

Aliment Pharmacol Ther. 2010 Feb 1;31(3):396-406. doi: 10.1111/j.1365-2036.2009.04181.x. Epub 2009 Oct 23.

42.

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.

Brunt EM, Kleiner DE, Wilson LA, Unalp A, Behling CE, Lavine JE, Neuschwander-Tetri BA; NASH Clinical Research NetworkA list of members of the Nonalcoholic Steatohepatitis Clinical Research Network can be found in the Appendix.

Hepatology. 2009 Mar;49(3):809-20. doi: 10.1002/hep.22724.

43.

Fast three-step method for shear moduli calculation from quartz crystal resonator measurements.

Behling C, Lucklum R, Hauptmann P.

IEEE Trans Ultrason Ferroelectr Freq Control. 1999;46(6):1431-8. doi: 10.1109/58.808866.

PMID:
18244339
44.

Signal amplification with multilayer arrangements on chemical quartz-crystal-resonator sensors.

Lucklum R, Behling C, Hauptmann P.

IEEE Trans Ultrason Ferroelectr Freq Control. 2000;47(5):1246-52. doi: 10.1109/58.869072.

PMID:
18238667
45.

Impact of abdominal helical computed tomography on the rate of negative appendicitis.

Guss DA, Behling CA, Munassi D.

J Emerg Med. 2008 Jan;34(1):7-11. Epub 2007 Dec 26.

PMID:
18155380
46.

EUS-guided FNA diagnostic yield of malignancy in solid pancreatic masses: a benchmark for quality performance measurement.

Savides TJ, Donohue M, Hunt G, Al-Haddad M, Aslanian H, Ben-Menachem T, Chen VK, Coyle W, Deutsch J, DeWitt J, Dhawan M, Eckardt A, Eloubeidi M, Esker A, Gordon SR, Gress F, Ikenberry S, Joyce AM, Klapman J, Lo S, Maluf-Filho F, Nickl N, Singh V, Wills J, Behling C.

Gastrointest Endosc. 2007 Aug;66(2):277-82.

PMID:
17643700
48.

Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.

Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE.

J Pediatr Gastroenterol Nutr. 2006 Oct;43(4):413-27. Review.

PMID:
17033514
49.

Prevalence of fatty liver in children and adolescents.

Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C.

Pediatrics. 2006 Oct;118(4):1388-93.

PMID:
17015527
50.

EUS for unexplained mediastinal lesions.

Savides TJ, Behling CM.

Endoscopy. 2006 Jun;38 Suppl 1:S73-6. Review. No abstract available.

PMID:
16802231

Supplemental Content

Loading ...
Support Center